List of Advil Pm drug patents
Advil Pm is owned by Glaxosmithkline.
Advil Pm contains Diphenhydramine Hydrochloride; Ibuprofen.
Advil Pm has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Advil Pm are:
- US8883849
- US9155718
Advil Pm was authorised for market use on 21 December, 2005.
Advil Pm is available in capsule;oral dosage forms.
Advil Pm can be used as a method of treating a patient suffering from a pain associated sleep disturbance comprising administering a liquid composition formulated inside a soft gel capsule, as claimed, to the patient.
The generics of Advil Pm are possible to be released after 17 January, 2022.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8883849 | GLAXOSMITHKLINE | Treatment of sleep disturbances |
Jan, 2022
(1 year, 4 months ago) | |
| US9155718 | GLAXOSMITHKLINE | Treatment of sleep disturbances |
Jan, 2022
(1 year, 4 months ago) | |
Drugs and Companies using DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN ingredient
Market Authorisation Date: 21 December, 2005
Treatment: A method of treating a patient suffering from a pain associated sleep disturbance comprising administering a liquid composition formulated inside a soft gel capsule, as claimed, to the patient
Dosage: CAPSULE;ORAL
ADVIL PM family patents
6
United States
2
Japan
1
Germany
1
Spain
1
Hong Kong
1
Austria
1
Canada
1
Mexico
1
Denmark
1
European Union
Advil Pm is owned by Glaxosmithkline.
Advil Pm contains Diphenhydramine Citrate; Ibuprofen.
Advil Pm has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Advil Pm are:
- US8263647
Advil Pm was authorised for market use on 21 December, 2005.
Advil Pm is available in tablet;oral dosage forms.
The generics of Advil Pm are possible to be released after 30 May, 2022.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8263647 | GLAXOSMITHKLINE | Treatment of sleep disturbances |
May, 2022
(11 months ago) | |
Drugs and Companies using DIPHENHYDRAMINE CITRATE; IBUPROFEN ingredient
Market Authorisation Date: 21 December, 2005
Treatment: NA
Dosage: TABLET;ORAL
ADVIL PM family patents
6
United States
2
Japan
1
Germany
1
Spain
1
Hong Kong
1
Austria
1
Canada
1
Mexico
1
Denmark
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic